Home › Funds › Crossingbridge Advisors, LLC › IPCX

Crossingbridge Advisors, LLC position in IPCX

ROIVANT SCIENCES LTD

Crossingbridge Advisors, LLC reported holding 1,235,944 shares of IPCX (ROIVANT SCIENCES LTD) in its Q2 2026 13F filing — a position valued at US$12.8M, representing 2.40% of its reported portfolio and ranking #4 among its reported holdings. Crossingbridge Advisors, LLC has disclosed IPCX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)1.24M sh
Reported value held$12.77M
Portfolio Weight2.40%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Crossingbridge Advisors, LLC's IPCX position evolved

Crossingbridge Advisors, LLC first disclosed a stake in IPCX in Q4 2025 at 649,756 shares (US$6.6M). The position peaked in Q1 2026 at 1,236,344 shares, worth US$12.9M. Across 3 filings, Crossingbridge Advisors, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,235,944 shares valued at US$12.8M. Notable position changes include a 90% increase in Q1 2026.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 649.76K $6.59M New
Q1 2026 1.24M $12.86M Add
Q2 2026 1.24M $12.77M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IPCX and 13F data

IPCX (ROIVANT SCIENCES LTD) is a company whose sector is not yet classified in our data. 60 other funds we track also report a position in IPCX — the largest reported positions include BERKLEY W R CORP (US$22.8M), LINDEN ADVISORS LP (US$19.2M), RLH Capital LLC (US$14.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IPCX

All IPCX fund holders →

FAQ

How long has Crossingbridge Advisors, LLC held IPCX?

Crossingbridge Advisors, LLC has disclosed IPCX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Crossingbridge Advisors, LLC's current position in IPCX?

As of Q2 2026, Crossingbridge Advisors, LLC holds 1.24M shares of IPCX (ROIVANT SCIENCES LTD), valued at $12.77M, representing 2.40% of its reported portfolio and ranking #4.

Has Crossingbridge Advisors, LLC been buying or selling IPCX?

In the latest 13F filing (Q2 2026), Crossingbridge Advisors, LLC held unchanged its position in IPCX. The position peaked in Q1 2026 at 1.24M shares.

Which other funds hold IPCX?

Other major institutional holders of IPCX include BERKLEY W R CORP, LINDEN ADVISORS LP, RLH Capital LLC, among 60 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.